{"component": "clause", "props": {"groups": [{"samples": [{"hash": "evPHLB6oAb3", "uri": "/contracts/evPHLB6oAb3#material-changes", "label": "Sales Agreement (Ernexa Therapeutics Inc.)", "score": 37.2026023865, "published": true}, {"hash": "9HLQnmOASmr", "uri": "/contracts/9HLQnmOASmr#material-changes", "label": "Atm Sales Agreement (Polar Power, Inc.)", "score": 36.761806488, "published": true}, {"hash": "1zcm0ss4QN7", "uri": "/contracts/1zcm0ss4QN7#material-changes", "label": "Atm Sales Agreement (Lantern Pharma Inc.)", "score": 36.5017127991, "published": true}], "size": 899, "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [23, 40]}, {"key": "reports-filed-with-the-commission", "type": "clause", "offset": [72, 105]}, {"key": "change-in", "type": "definition", "offset": [154, 163]}, {"key": "capital-stock-of-the-company", "type": "clause", "offset": [179, 207]}, {"key": "cause-a-material-adverse-effect", "type": "definition", "offset": [295, 326]}, {"key": "withdrawal-of", "type": "clause", "offset": [351, 364]}, {"key": "asset-backed-securities", "type": "definition", "offset": [432, 455]}, {"key": "rating-organization", "type": "definition", "offset": [464, 483]}, {"key": "public-announcement", "type": "clause", "offset": [489, 508]}, {"key": "effect-of", "type": "clause", "offset": [665, 674]}, {"key": "in-the-case", "type": "clause", "offset": [682, 693]}, {"key": "action-by", "type": "clause", "offset": [706, 715]}, {"key": "the-agent", "type": "clause", "offset": [785, 794]}, {"key": "the-offering", "type": "definition", "offset": [955, 967]}, {"key": "the-placement-shares", "type": "clause", "offset": [971, 991]}, {"key": "terms-and", "type": "clause", "offset": [999, 1008]}], "snippet": "Except as contemplated in the Prospectus, or disclosed in the Company\u2019s reports filed with the Commission, there shall not have been any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would reasonably be expected to cause a Material Adverse Effect, or a downgrading in or withdrawal of the rating assigned to any of the Company\u2019s securities (other than asset backed securities) by any rating organization or a public announcement by any rating organization that it has under surveillance or review its rating of any of the Company\u2019s securities (other than asset backed securities), the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of the Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.", "hash": "f849e6eec5ba125c882dcda7b05e85d2", "id": 1}, {"samples": [{"hash": "k53vm2ZuwKF", "uri": "/contracts/k53vm2ZuwKF#material-changes", "label": "Professional Service Contract", "score": 36.3936767578, "published": true}, {"hash": "iFVk9LVwpYg", "uri": "/contracts/iFVk9LVwpYg#material-changes", "label": "Client Service Contract", "score": 36.1163253784, "published": true}, {"hash": "PpA8DTrRdV", "uri": "/contracts/PpA8DTrRdV#material-changes", "label": "Services Contract", "score": 35.3527908325, "published": true}], "size": 174, "snippet_links": [{"key": "the-insurer-shall", "type": "clause", "offset": [0, 17]}, {"key": "point-of-contact", "type": "definition", "offset": [32, 48]}, {"key": "cancellation-or-non", "type": "clause", "offset": [119, 138]}, {"key": "insurance-policy", "type": "clause", "offset": [154, 170]}, {"key": "under-this-contract", "type": "clause", "offset": [180, 199]}, {"key": "payment-of-premium", "type": "clause", "offset": [231, 249]}, {"key": "failure-to-provide-notice", "type": "clause", "offset": [327, 352]}, {"key": "as-required", "type": "clause", "offset": [353, 364]}, {"key": "termination-of-the-contract", "type": "clause", "offset": [379, 406]}], "snippet": "The insurer shall give the DSHS point of contact listed on page one of this Contract 45 days advance written notice of cancellation or non-renewal of any insurance policy required under this Contract. If cancellation is due to non-payment of premium, the insurer shall give DSHS 10 days advance written notice of cancellation. Failure to provide notice as required may result in termination of the Contract.", "hash": "2a1b9bbe1df53ad0acdcc0a2adcf43c9", "id": 10}, {"samples": [{"hash": "4ZvBVQ6krE3", "uri": "/contracts/4ZvBVQ6krE3#material-changes", "label": "Securities Purchase Agreement (Sinobiomed Inc)", "score": 22.508556366, "published": true}, {"hash": "5EBKGmaxEQj", "uri": "/contracts/5EBKGmaxEQj#material-changes", "label": "Securities Purchase Agreement (Thermoenergy Corp)", "score": 21.6023273468, "published": true}, {"hash": "lglpGpUfzLg", "uri": "/contracts/lglpGpUfzLg#material-changes", "label": "Securities Purchase Agreement (Thermoenergy Corp)", "score": 21.0, "published": true}], "size": 357, "snippet_links": [{"key": "date-of", "type": "clause", "offset": [10, 17]}, {"key": "latest-audited-financial-statements", "type": "definition", "offset": [22, 57]}, {"key": "the-sec-reports", "type": "definition", "offset": [74, 89]}, {"key": "specifically-disclosed", "type": "definition", "offset": [101, 123]}, {"key": "no-event", "type": "clause", "offset": [163, 171]}, {"key": "could-reasonably-be-expected-to", "type": "definition", "offset": [220, 251]}, {"key": "material-adverse-effect", "type": "definition", "offset": [264, 287]}, {"key": "the-company-has", "type": "clause", "offset": [294, 309]}, {"key": "trade-payables", "type": "clause", "offset": [380, 394]}, {"key": "expenses-and", "type": "clause", "offset": [404, 416]}, {"key": "liabilities-incurred", "type": "clause", "offset": [423, 443]}, {"key": "in-the-ordinary-course-of-business", "type": "definition", "offset": [444, 478]}, {"key": "consistent-with-past-practice", "type": "clause", "offset": [479, 508]}, {"key": "not-required", "type": "definition", "offset": [529, 541]}, {"key": "pursuant-to", "type": "clause", "offset": [596, 607]}, {"key": "required-to-be-disclosed", "type": "clause", "offset": [616, 640]}, {"key": "filings-made", "type": "clause", "offset": [644, 656]}, {"key": "the-commission", "type": "clause", "offset": [662, 676]}, {"key": "method-of-accounting", "type": "clause", "offset": [716, 736]}, {"key": "distribution-of-cash", "type": "clause", "offset": [828, 848]}, {"key": "other-property", "type": "definition", "offset": [852, 866]}, {"key": "shares-of", "type": "clause", "offset": [959, 968]}, {"key": "capital-stock", "type": "clause", "offset": [973, 986]}, {"key": "equity-securities", "type": "definition", "offset": [1027, 1044]}, {"key": "company-stock-option-plans", "type": "definition", "offset": [1112, 1138]}, {"key": "confidential-treatment-of-information", "type": "clause", "offset": [1212, 1249]}], "snippet": "Since the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables, accrued expenses and other liabilities incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company\u2019s financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting or the identity of its auditors, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information.", "hash": "a08ad177ca668e784798a70ea4917068", "id": 4}, {"samples": [{"hash": "4ZCvghSQ2bV", "uri": "/contracts/4ZCvghSQ2bV#material-changes", "label": "At Market Issuance Sales Agreement (Cherry Hill Mortgage Investment Corp)", "score": 35.6036949158, "published": true}, {"hash": "1yEw6je1weK", "uri": "/contracts/1yEw6je1weK#material-changes", "label": "At Market Issuance Sales Agreement (Star Equity Holdings, Inc.)", "score": 35.3750839233, "published": true}, {"hash": "kX0L4xuxcdN", "uri": "/contracts/kX0L4xuxcdN#material-changes", "label": "Sales Agreement (CorMedix Inc.)", "score": 35.35181427, "published": true}], "size": 179, "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [23, 40]}, {"key": "reports-filed-with-the-commission", "type": "clause", "offset": [72, 105]}, {"key": "could-reasonably-be-expected-to", "type": "definition", "offset": [186, 217]}, {"key": "cause-a-material-adverse-effect", "type": "definition", "offset": [218, 249]}, {"key": "withdrawal-of", "type": "clause", "offset": [274, 287]}, {"key": "of-the-company", "type": "clause", "offset": [315, 329]}, {"key": "asset-backed-securities", "type": "definition", "offset": [355, 378]}, {"key": "rating-organization", "type": "definition", "offset": [387, 406]}, {"key": "public-announcement", "type": "clause", "offset": [412, 431]}, {"key": "effect-of", "type": "clause", "offset": [588, 597]}, {"key": "in-the-case", "type": "clause", "offset": [605, 616]}, {"key": "action-by", "type": "clause", "offset": [629, 638]}, {"key": "the-agent", "type": "clause", "offset": [708, 717]}, {"key": "the-offering", "type": "definition", "offset": [878, 890]}, {"key": "the-placement-shares", "type": "clause", "offset": [894, 914]}, {"key": "terms-and", "type": "clause", "offset": [922, 931]}], "snippet": "Except as contemplated in the Prospectus, or disclosed in the Company\u2019s reports filed with the Commission, there shall not have been any Material Adverse Effect, or any development that could reasonably be expected to cause a Material Adverse Effect, or a downgrading in or withdrawal of the rating assigned to any of the Company\u2019s securities (other than asset backed securities) by any rating organization or a public announcement by any rating organization that it has under surveillance or review its rating of any of the Company\u2019s securities (other than asset backed securities), the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of the Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.", "hash": "bce0164ff8c1c1639c4793543ffc362a", "id": 9}, {"samples": [{"hash": "lhCJMMOUKuu", "uri": "/contracts/lhCJMMOUKuu#material-changes", "label": "Securities Purchase Agreement (Becoming Art Inc)", "score": 21.0, "published": true}, {"hash": "kdtegP3cs9a", "uri": "/contracts/kdtegP3cs9a#material-changes", "label": "Securities Purchase Agreement (LML Payment Systems Inc)", "score": 21.0, "published": true}, {"hash": "kd7yydntrLp", "uri": "/contracts/kd7yydntrLp#material-changes", "label": "Securities Purchase Agreement (Isonics Corp)", "score": 21.0, "published": true}], "size": 563, "snippet_links": [{"key": "date-of", "type": "clause", "offset": [10, 17]}, {"key": "latest-audited-financial-statements", "type": "definition", "offset": [22, 57]}, {"key": "the-sec-reports", "type": "definition", "offset": [74, 89]}, {"key": "specifically-disclosed", "type": "definition", "offset": [101, 123]}, {"key": "no-event", "type": "clause", "offset": [163, 171]}, {"key": "could-reasonably-be-expected-to", "type": "definition", "offset": [220, 251]}, {"key": "material-adverse-effect", "type": "definition", "offset": [264, 287]}, {"key": "the-company-has", "type": "clause", "offset": [294, 309]}, {"key": "trade-payables", "type": "clause", "offset": [380, 394]}, {"key": "expenses-incurred", "type": "clause", "offset": [407, 424]}, {"key": "in-the-ordinary-course-of-business", "type": "definition", "offset": [425, 459]}, {"key": "consistent-with-past-practice", "type": "clause", "offset": [460, 489]}, {"key": "not-required", "type": "definition", "offset": [510, 522]}, {"key": "pursuant-to", "type": "clause", "offset": [577, 588]}, {"key": "required-to-be-disclosed", "type": "clause", "offset": [597, 621]}, {"key": "filings-made", "type": "clause", "offset": [625, 637]}, {"key": "the-commission", "type": "clause", "offset": [643, 657]}, {"key": "method-of-accounting", "type": "clause", "offset": [697, 717]}, {"key": "distribution-of-cash", "type": "clause", "offset": [777, 797]}, {"key": "other-property", "type": "definition", "offset": [801, 815]}, {"key": "shares-of", "type": "clause", "offset": [908, 917]}, {"key": "capital-stock", "type": "clause", "offset": [922, 935]}, {"key": "equity-securities", "type": "definition", "offset": [975, 992]}, {"key": "company-stock-option-plans", "type": "definition", "offset": [1060, 1086]}, {"key": "confidential-treatment-of-information", "type": "clause", "offset": [1160, 1197]}], "snippet": "Since the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company's financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information.", "hash": "1cf28005be62c3478a38e0384cd79031", "id": 2}, {"samples": [{"hash": "dsnVcT2w9kj", "uri": "/contracts/dsnVcT2w9kj#material-changes", "label": "At Market Sales Agreement (ZJK Industrial Co., Ltd.)", "score": 37.5886383057, "published": true}, {"hash": "eS4YubwnWtY", "uri": "/contracts/eS4YubwnWtY#material-changes", "label": "At Market Sales Agreement (Wetour Robotics LTD)", "score": 37.3668708801, "published": true}, {"hash": "7oKwLQ8Mi2b", "uri": "/contracts/7oKwLQ8Mi2b#material-changes", "label": "Atm Sales Agreement (NovaBay Pharmaceuticals, Inc.)", "score": 37.0520210266, "published": true}], "size": 215, "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [23, 40]}, {"key": "reports-filed-with-the-commission", "type": "clause", "offset": [72, 105]}, {"key": "cause-a-material-adverse-effect", "type": "definition", "offset": [192, 223]}, {"key": "withdrawal-of", "type": "clause", "offset": [248, 261]}, {"key": "of-the-company", "type": "clause", "offset": [289, 303]}, {"key": "asset-backed-securities", "type": "definition", "offset": [329, 352]}, {"key": "nationally-recognized-statistical-rating-organization", "type": "definition", "offset": [362, 415]}, {"key": "by-the-commission", "type": "clause", "offset": [442, 459]}, {"key": "for-purposes-of", "type": "clause", "offset": [460, 475]}, {"key": "the-securities-act", "type": "clause", "offset": [497, 515]}, {"key": "public-announcement", "type": "clause", "offset": [548, 567]}, {"key": "effect-of", "type": "clause", "offset": [724, 733]}, {"key": "in-the-case", "type": "clause", "offset": [741, 752]}, {"key": "action-by", "type": "clause", "offset": [765, 774]}, {"key": "the-agent", "type": "clause", "offset": [844, 853]}, {"key": "the-offering", "type": "definition", "offset": [1014, 1026]}, {"key": "the-placement-shares", "type": "clause", "offset": [1030, 1050]}, {"key": "terms-and", "type": "clause", "offset": [1058, 1067]}], "snippet": "Except as contemplated in the Prospectus, or disclosed in the Company\u2019s reports filed with the Commission, there shall not have been any Material Adverse Effect, or any development that would cause a Material Adverse Effect, or a downgrading in or withdrawal of the rating assigned to any of the Company\u2019s securities (other than asset backed securities) by any \u201cnationally recognized statistical rating organization,\u201d as such term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act (a \u201cRating Organization\u201d), or a public announcement by any Rating Organization that it has under surveillance or review its rating of any of the Company\u2019s securities (other than asset backed securities), the effect of which, in the case of any such action by a Rating Organization described above, in the reasonable judgment of the Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.", "hash": "3c150495ec325e62cb5605e31aa97266", "id": 7}, {"samples": [{"hash": "FhOJNgD5pw", "uri": "/contracts/FhOJNgD5pw#material-changes", "label": "Securities Purchase Agreement (SANUWAVE Health, Inc.)", "score": 35.4695396423, "published": true}, {"hash": "gVjsMzrIQ1e", "uri": "/contracts/gVjsMzrIQ1e#material-changes", "label": "Securities Purchase Agreement (SANUWAVE Health, Inc.)", "score": 35.0643386841, "published": true}, {"hash": "iQMp7FizAxL", "uri": "/contracts/iQMp7FizAxL#material-changes", "label": "Securities Purchase Agreement (SANUWAVE Health, Inc.)", "score": 35.004108429, "published": true}], "size": 210, "snippet_links": [{"key": "date-of", "type": "clause", "offset": [10, 17]}, {"key": "latest-audited-financial-statements", "type": "definition", "offset": [22, 57]}, {"key": "the-sec-reports", "type": "definition", "offset": [70, 85]}, {"key": "specifically-disclosed", "type": "definition", "offset": [97, 119]}, {"key": "report-filed", "type": "definition", "offset": [140, 152]}, {"key": "prior-to-the", "type": "clause", "offset": [153, 165]}, {"key": "date-hereof", "type": "clause", "offset": [166, 177]}, {"key": "no-event", "type": "clause", "offset": [198, 206]}, {"key": "material-adverse-effect", "type": "definition", "offset": [299, 322]}, {"key": "the-company-has", "type": "clause", "offset": [329, 344]}, {"key": "trade-payables", "type": "clause", "offset": [415, 429]}, {"key": "expenses-incurred", "type": "clause", "offset": [442, 459]}, {"key": "in-the-ordinary-course-of-business", "type": "definition", "offset": [460, 494]}, {"key": "consistent-with-past-practice", "type": "clause", "offset": [495, 524]}, {"key": "not-required", "type": "definition", "offset": [545, 557]}, {"key": "pursuant-to", "type": "clause", "offset": [612, 623]}, {"key": "filings-made", "type": "clause", "offset": [645, 657]}, {"key": "the-commission", "type": "clause", "offset": [663, 677]}, {"key": "method-of-accounting", "type": "clause", "offset": [717, 737]}, {"key": "distribution-of-cash", "type": "clause", "offset": [797, 817]}, {"key": "other-property", "type": "definition", "offset": [821, 835]}, {"key": "shares-of", "type": "clause", "offset": [928, 937]}, {"key": "capital-stock", "type": "clause", "offset": [942, 955]}, {"key": "equity-securities", "type": "definition", "offset": [995, 1012]}, {"key": "common-stock-equivalents", "type": "clause", "offset": [1016, 1040]}, {"key": "company-equity-incentive-plans", "type": "definition", "offset": [1108, 1138]}, {"key": "confidential-treatment-of-information", "type": "clause", "offset": [1212, 1249]}, {"key": "issuance-of-the-securities", "type": "clause", "offset": [1266, 1292]}, {"key": "contemplated-by-this-agreement", "type": "clause", "offset": [1293, 1323]}, {"key": "with-respect-to-the-company", "type": "clause", "offset": [1529, 1556]}, {"key": "financial-condition", "type": "clause", "offset": [1643, 1662]}, {"key": "required-to-be-disclosed", "type": "clause", "offset": [1678, 1702]}, {"key": "applicable-securities-laws", "type": "clause", "offset": [1724, 1750]}, {"key": "registration-statement-on-form-s-1", "type": "clause", "offset": [1756, 1790]}, {"key": "relating-to", "type": "definition", "offset": [1810, 1821]}, {"key": "issuance-and-sale-by-the-company", "type": "clause", "offset": [1825, 1857]}, {"key": "publicly-announced", "type": "definition", "offset": [1901, 1919]}], "snippet": "Since the date of the latest audited financial statements included in the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof: (i) there has been no event, occurrence or development that has had or that would reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company\u2019s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities or Common Stock Equivalents to any officer, director or Affiliate, except pursuant to existing Company equity incentive plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement and as may otherwise be disclosed herein or in any SEC Reports hereto, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under applicable securities laws on a registration statement on Form S-1 filed with the SEC relating to an issuance and sale by the Company of its Common Stock and which has not been publicly announced.", "hash": "ecb1344f8eb2e47df1b239b01ede0db4", "id": 8}, {"samples": [{"hash": "94oj0zRlAy2", "uri": "/contracts/94oj0zRlAy2#material-changes", "label": "Equity Distribution Agreement (Terreno Realty Corp)", "score": 37.1286773682, "published": true}, {"hash": "h7eVXAtDiJ9", "uri": "/contracts/h7eVXAtDiJ9#material-changes", "label": "Equity Distribution Agreement (Whitestone REIT)", "score": 36.7070503235, "published": true}, {"hash": "hxjCEIkjntt", "uri": "/contracts/hxjCEIkjntt#material-changes", "label": "Equity Distribution Agreement (Terreno Realty Corp)", "score": 35.6557159424, "published": true}], "size": 479, "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [23, 40]}, {"key": "reports-filed-with-the-commission", "type": "clause", "offset": [72, 105]}, {"key": "change-in", "type": "definition", "offset": [154, 163]}, {"key": "the-condition", "type": "clause", "offset": [164, 177]}, {"key": "business-affairs", "type": "clause", "offset": [223, 239]}, {"key": "business-prospects", "type": "clause", "offset": [243, 261]}, {"key": "the-company-and-its-subsidiaries", "type": "clause", "offset": [265, 297]}, {"key": "in-the-ordinary-course-of-business", "type": "definition", "offset": [351, 385]}], "snippet": "Except as contemplated in the Prospectus, or disclosed in the Company\u2019s reports filed with the Commission, there shall not have been any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business.", "hash": "b3c788e1665eecd1d715000e22067a8e", "id": 3}, {"samples": [{"hash": "kJx9bdQCq6U", "uri": "/contracts/kJx9bdQCq6U#material-changes", "label": "Sales Agreement (Entrada Therapeutics, Inc.)", "score": 34.7412719727, "published": true}, {"hash": "e6spVr1TPlD", "uri": "/contracts/e6spVr1TPlD#material-changes", "label": "Sales Agreement (Adverum Biotechnologies, Inc.)", "score": 34.3552360535, "published": true}, {"hash": "9dNCU4FwP1q", "uri": "/contracts/9dNCU4FwP1q#material-changes", "label": "Common Stock Sales Agreement (Eos Energy Enterprises, Inc.)", "score": 33.5913772583, "published": true}], "size": 349, "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [23, 40]}, {"key": "reports-filed-with-the-commission", "type": "clause", "offset": [72, 105]}, {"key": "consolidated-basis", "type": "clause", "offset": [167, 185]}, {"key": "capital-stock-of-the-company", "type": "clause", "offset": [205, 233]}, {"key": "a-material-adverse-change", "type": "clause", "offset": [331, 356]}, {"key": "withdrawal-of", "type": "clause", "offset": [383, 396]}, {"key": "asset-backed-securities", "type": "definition", "offset": [464, 487]}, {"key": "rating-organization", "type": "definition", "offset": [496, 515]}, {"key": "public-announcement", "type": "clause", "offset": [521, 540]}, {"key": "effect-of", "type": "clause", "offset": [697, 706]}, {"key": "in-the-case", "type": "clause", "offset": [714, 725]}, {"key": "action-by", "type": "clause", "offset": [738, 747]}, {"key": "the-offering", "type": "definition", "offset": [983, 995]}, {"key": "the-placement-shares", "type": "clause", "offset": [999, 1019]}, {"key": "terms-and", "type": "clause", "offset": [1027, 1036]}], "snippet": "Except as contemplated in the Prospectus, or disclosed in the Company\u2019s reports filed with the Commission, there shall not have been any material adverse change, on a consolidated basis, in the authorized capital stock of the Company or any Material Adverse Change or any development that would reasonably be expected to result in a Material Adverse Change, or any downgrading in or withdrawal of the rating assigned to any of the Company\u2019s securities (other than asset backed securities) by any rating organization or a public announcement by any rating organization that it has under surveillance or review its rating of any of the Company\u2019s securities (other than asset backed securities), the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of Cowen (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.", "hash": "a23c1c311fcb8da844701607e173eb49", "id": 5}, {"samples": [{"hash": "f4glYNTaBPX", "uri": "/contracts/f4glYNTaBPX#material-changes", "label": "At the Market Issuance Sales Agreement (American Homes 4 Rent)", "score": 37.4435310364, "published": true}, {"hash": "eNz00RqCxzZ", "uri": "/contracts/eNz00RqCxzZ#material-changes", "label": "Equity Distribution Agreement (Extra Space Storage LP)", "score": 35.2861061096, "published": true}, {"hash": "SgiwJthDSV", "uri": "/contracts/SgiwJthDSV#material-changes", "label": "At the Market Issuance Sales Agreement (American Homes 4 Rent)", "score": 34.4346351624, "published": true}], "size": 223, "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [23, 40]}, {"key": "the-company", "type": "clause", "offset": [58, 69]}, {"key": "reports-filed-with-the-commission", "type": "clause", "offset": [72, 105]}, {"key": "material-adverse-effect", "type": "definition", "offset": [137, 160]}], "snippet": "Except as contemplated in the Prospectus, or disclosed in the Company\u2019s reports filed with the Commission, there shall not have been any Material Adverse Effect.", "hash": "1cd544b373cf1041c7a908d7feb6a0b3", "id": 6}], "next_curs": "ClkSU2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjULEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhltYXRlcmlhbC1jaGFuZ2VzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"parents": [["representations-and-warranties-of-the-company", "Representations and Warranties of the Company"], ["representations-and-warranties", "Representations and Warranties"], ["conditions-to-the-agents-obligations", "Conditions to the Agent\u2019s Obligations"], ["conditions-to-agents-obligations", "Conditions to Agent\u2019s Obligations"], ["conditions-to-\u2587\u2587\u2587\u2587\u2587\u2587-obligations", "Conditions to \u2587\u2587\u2587\u2587\u2587\u2019\u2587 Obligations"]], "size": 8704, "children": [["", ""], ["litigation", "Litigation"], ["title-to-assets", "Title to Assets"], ["compliance", "Compliance"], ["regulatory-permits", "Regulatory Permits"]], "title": "Material Changes", "id": "material-changes", "related": [["material-change", "Material Change", "Material Change"], ["no-material-changes", "No Material Changes", "No <strong>Material Changes</strong>"], ["material-change-in-business", "Material Change in Business", "Material Change in Business"], ["absence-of-material-changes", "Absence of Material Changes", "Absence of <strong>Material Changes</strong>"], ["no-adverse-material-change", "No Adverse Material Change", "No Adverse Material Change"]], "related_snippets": [], "updated": "2026-08-13T04:22:21+00:00", "also_ask": ["What objective criteria should define a 'material change' to avoid ambiguity?", "How can parties negotiate thresholds or carve-outs for material changes to protect their interests?", "What are the most common pitfalls in drafting material change clauses that lead to unenforceability?", "How do courts typically interpret and enforce material change provisions in similar contracts?", "What industry-specific standards or benchmarks should be referenced when defining material changes?"], "drafting_tip": "Define 'material change' precisely to avoid ambiguity; specify notification procedures to ensure timely awareness; require written consent for changes to protect party interests.", "explanation": "The Material Changes clause defines the process and requirements for handling significant alterations to the terms, conditions, or scope of an agreement. Typically, this clause outlines what constitutes a 'material' change\u2014such as major adjustments to pricing, deliverables, or timelines\u2014and may require that such changes be documented in writing and agreed upon by all parties. Its core practical function is to ensure that both parties are aware of and consent to substantial modifications, thereby preventing misunderstandings and disputes over unapproved or unilateral changes."}, "json": true, "cursor": ""}}